Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp(University Hospital of Lausanne), Monika E. Hegi(University of Lausanne), Warren Mason(Princess Margaret Cancer Centre), Martin J. van den Bent(Erasmus University Rotterdam), Martin Taphoorn(University Medical Center Utrecht), Robert C. Janzer(University of Lausanne), Samuel K. Ludwin(Queen's University), Anouk Allgeier(European Organisation for Research and Treatment of Cancer), Barbara Fisher(Western University), Karl Bélanger(Hôpital Notre-Dame), Peter Hau, Alba A. Brandes, Johanna M. M. Gijtenbeek(Radboud University Medical Center), Christine Marosi(Medical University of Vienna), Charles J. Vecht(Erasmus University Rotterdam), Karima Mokhtari(Sorbonne Université), Pieter Wesseling(Radboud University Nijmegen), S. Villà(Institut Català d'Oncologia), Elizabeth A. Eisenhauer(Ontario Institute for Cancer Research), Thierry Gorlia(European Organisation for Research and Treatment of Cancer), Michael Weller(University of Tübingen), Denis Lacombe(European Organisation for Research and Treatment of Cancer), J. Gregory Cairncross(University of Calgary), René‐Olivier Mirimanoff(University of Lausanne)
Cited by 7,770
Abstract
Related Papers
No related papers found
Powered by citation graph analysis